Study to Characterize the Effects of Cytochrome p450 1A2 Inhibition on Systemic Exposure to BMS-986165
Clinical trial NCT03930602 · COMPLETED
Trial details
- NCT number
- NCT03930602
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-05-01
- Primary completion
- 2019-05-27
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.